202 related articles for article (PubMed ID: 19582779)
21. Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325.
Peck D; Isacke CM
J Cell Sci; 1998 Jun; 111 ( Pt 11)():1595-601. PubMed ID: 9580567
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
23. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells.
Neame SJ; Isacke CM
EMBO J; 1992 Dec; 11(13):4733-8. PubMed ID: 1281449
[TBL] [Abstract][Full Text] [Related]
25. SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2.
Xu M; Jiang H; Wang H; Liu J; Liu B; Guo Z
Oncol Rep; 2018 Aug; 40(2):726-736. PubMed ID: 29917166
[TBL] [Abstract][Full Text] [Related]
26. DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.
Iida J; Clancy R; Dorchak J; Somiari RI; Somiari S; Cutler ML; Mural RJ; Shriver CD
PLoS One; 2014; 9(2):e88712. PubMed ID: 24586375
[TBL] [Abstract][Full Text] [Related]
27. Stress-response protein RBM3 attenuates the stem-like properties of prostate cancer cells by interfering with CD44 variant splicing.
Zeng Y; Wodzenski D; Gao D; Shiraishi T; Terada N; Li Y; Vander Griend DJ; Luo J; Kong C; Getzenberg RH; Kulkarni P
Cancer Res; 2013 Jul; 73(13):4123-33. PubMed ID: 23667174
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
Lee YM; Kim JM; Lee HJ; Seong IO; Kim KH
Urol Oncol; 2019 Oct; 37(10):742-748. PubMed ID: 31053527
[TBL] [Abstract][Full Text] [Related]
29. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
30. siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468).
Vahidian F; Safarzadeh E; Mohammadi A; Najjary S; Mansoori B; Majidi J; Babaloo Z; Aghanejad A; Shadbad MA; Mokhtarzadeh A; Baradaran B
Mol Biol Rep; 2020 Dec; 47(12):9541-9551. PubMed ID: 33206362
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin induces beta-catenin signaling through activation of Akt in prostate cancer cells.
Robertson BW; Chellaiah MA
Exp Cell Res; 2010 Jan; 316(1):1-11. PubMed ID: 19850036
[TBL] [Abstract][Full Text] [Related]
32. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin Regulates Hepatitis C Virus (HCV) Replication and Assembly by Interacting with HCV Proteins and Lipid Droplets and by Binding to Receptors αVβ3 and CD44.
Iqbal J; Sarkar-Dutta M; McRae S; Ramachandran A; Kumar B; Waris G
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669827
[TBL] [Abstract][Full Text] [Related]
34. [Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells].
Liu H; Chen AM; Guo FJ; Liao H; Hu WH; Xie J
Chin J Cancer; 2010 Jan; 29(1):43-51. PubMed ID: 20038310
[TBL] [Abstract][Full Text] [Related]
35. CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells.
Senbanjo LT; Chellaiah MA
Front Cell Dev Biol; 2017; 5():18. PubMed ID: 28326306
[TBL] [Abstract][Full Text] [Related]
36. [CD44 variant increases the invasive ability of human breast cancer cell line MCF-7 cells].
Fang XJ; Xu WL; Gong JL; Chen C; Fang LL; Chen QY
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):22-8. PubMed ID: 20211062
[TBL] [Abstract][Full Text] [Related]
37. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
[TBL] [Abstract][Full Text] [Related]
38. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia.
Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K
Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233
[TBL] [Abstract][Full Text] [Related]
39. CD44 is not an adhesive receptor for osteopontin.
Smith LL; Greenfield BW; Aruffo A; Giachelli CM
J Cell Biochem; 1999 Apr; 73(1):20-30. PubMed ID: 10088720
[TBL] [Abstract][Full Text] [Related]
40. Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.
Kopp R; Fichter M; Assert R; Pfeiffer AF; Classen S
Int J Mol Med; 2009 May; 23(5):639-49. PubMed ID: 19360323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
